Here’s a brief video (subtitles available) looking at some of the issues that might be encountered when protecting innovation in the “Internet of Things”.
Mark Richardson 24 June 2020
Here’s a few thoughts I recorded a couple of weeks ago (in 60 seconds against a stopwatch!) for reducing patent spend in light of challenges resulting from the Coronavirus pandemic. This video is subtitled.
Mark Richardson 16 June 2020
Last week in “Patenting AI/Machine Learning Inventions (Part 1)” Richard Lawrence and I discussed the challenges of patenting artificial intelligence and machine learning inventions. At the end of that video Richard promised me an example “with a dog”.
So, here’s part 2 of the video. Again, the video is provided with subtitles.
Mark Richardson 20 May 2020
Artificial Intelligence (AI) is appearing in every technology and industrial sector and has been accompanied by an increase in patent activity over recent years. In this video (subtitles available) I discuss the challenges of patenting artificial intelligence and machine learning inventions with Richard Lawrence of Keltie.
Part 2 of this video will be published next week on IPcopy.
Mark Richardson 13 May 2020
In response to the Coronavirus pandemic the EPO has adopted a number of special measures including the postponement until further notice of oral proceedings in examination and opposition proceedings unless they are scheduled to take place by video conference (or the applicant is willing to convert the proceedings into oral proceedings using video conference).
The use of video conferencing has therefore, for the moment at least, become the default for oral proceedings in front of the Examining Division. However, video conferencing during the Covid-19 pandemic brings a number of additional challenges compared to the normal use of the technology. (more…)
The unitary patent project and the Unified Patent Court have been limping along in recent years ever since the result of the UK referendum on EU membership and the filing of the German constitutional court challenge against the UPC legislation.
This blog has been less than positive (1, 2) about the prospect of either the UK staying in the system or even the outlook for the project as a whole and yesterday it became clear that, contrary to previous slightly more positive murmurings from the UK Government, the UK has now decided it will not be moving forward in the Unified Patent Court system. Despite the lack of an official announcement the news seemed to pop up online and in IPcopy’s messages from a number of different sources yesterday and IAM Magazine later reported that the Prime Minister’s Office confirmed that the UK would not be participating in the UPC system. (more…)
It’s General Election time. Again.
Even though the UK has been through four major votes since 2014 (Scottish Referendum in 2014, General Election in 2015, EU Referendum in 2016, General Election in 2017) the Powers That Be were clearly spooked by the lack of an opportunity for the UK electorate to vote on something major in 2018 and so are bringing us General Election 3: It’s Brexmas Time (There’s No Need to be Afraid).
The main parties might want you to believe that the election is about the chance to ruin our relationship with our main trading partners even further or the ability to nationalise anything that moves but we all really know where the main policy action is. Yes, it’s time to see what the parties have to say about IP.
IPcopy has therefore taken one for the team and has waded through the manifestos for the Conservatives, Labour, the Liberal Democrats, Plaid Cymru, the Green Party and the SNP (and also the Brexit Party’s “Contract with the People”) to see what they have to say about: patents, trade marks, designs (IP related design references), copyright, the unitary patent and unified patent court. We’ve also had a look to see what’s been said about research and development.
So, ready? Here we go…. (more…)
IPcopy recently attended an EPO presentation from the EPO’s Bioinformatics team on the subject of computer implemented inventions (CII) in biotech and healthcare and how to go about patenting such inventions.
This author works in Keltie’s software team and so is familiar with CII related inventions. Bioinformatics inventions however can sit somewhere between the biotech and software disciplines and so this presentation provided a handy insight for attorneys from either field into the subject area. (more…)
In the first session, “Patenting Computer implemented inventions in Healthcare at the EPO”, Igor Dydenko provided the EPO view on patenting inventions in the Healthcare field which apparently is the top technical field with the most patent applications in the EPO (according to the EPO’s 2018 annual report).
Igor noted that the relevant provisions for healthcare related inventions were those relating to technicality (Art 52(2), (3) and 56 EPC) and medical methods (Art 53(c) EPC). A review of the two examination requirements (note the EPO moving away from the “hurdles” language*) of technicality and inventive step then followed which highlighted the Guidelines for Examination approach for mixed type inventions incorporating a mathematical method (see G-II, 3.3). In particular the discussion highlighted the requirement for inventive step to only be supported by those features of the claimed invention which provide a technical effect serving a technical purpose. (more…)
Last Tuesday the UK’s Supreme Court delivered their verdict in the “prorogation of Parliament” case and found that the advice provided to the Queen was unlawful with the effect that prorogation had never happened. Parliament was duly recalled on Wednesday where the Speaker directed that the item in the Journal of the House of Commons relating to Prorogation was to be expunged and replaced with a reference to the House being adjourned instead.
The Commons session last Wednesday went ahead with a series of Urgent Questions and the atmosphere in the chamber steadily deteriorated as things went on. Last week also marked the return to UK TV of the show The Good Place, and in honour of that show and its main character Eleanor Shellstrop, the session in Parliament last Wednesday could probably fairly be summed up as a forking shirtshow.
Lost a little in the noise generated by the Supreme Court decision and the subsequent recall of Parliament however was an announcement from Labour in Jeremy Corbyn’s conference speech (and associated policy paper) regarding medicines and the use of the patent system. (more…)